{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:05:48Z","timestamp":1794330348831,"version":"4.9.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T00:00:00Z","timestamp":1643760000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.biopha.2022.112686","type":"journal-article","created":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T19:12:53Z","timestamp":1643915573000},"page":"112686","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"special_numbering":"C","title":["Oxamate targeting aggressive cancers with special emphasis to brain tumors"],"prefix":"10.1016","volume":"147","author":[{"given":"Meric A.","family":"Altinoz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysel","family":"Ozpinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2022.112686_bib1","series-title":"Global Cancer Observatory: Cancer Today","author":"Ferlay","year":"2020"},{"issue":"2","key":"10.1016\/j.biopha.2022.112686_bib2","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3390\/cells10020202","article-title":"Beyond the Warburg effect: oxidative and glycolytic phenotypes coexist within the metabolic heterogeneity of glioblastoma","volume":"10","author":"Duraj","year":"2021","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.biopha.2022.112686_bib3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/brainsci8040056","article-title":"Oxamate, but not selective targeting of LDH-A, inhibits medulloblastoma cell glycolysis, growth and motility","volume":"8","author":"Valvona","year":"2018","journal-title":"Brain Sci."},{"issue":"7","key":"10.1016\/j.biopha.2022.112686_bib4","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1055\/a-1525-2131","article-title":"Treatment strategies for dopamine agonist-resistant and aggressive prolactinomas: a comprehensive analysis of the literature","volume":"53","author":"Sari","year":"2021","journal-title":"Horm. Metab. Res."},{"issue":"1","key":"10.1016\/j.biopha.2022.112686_bib5","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.1038\/s41598-017-04366-5","article-title":"Lactate dehydrogenase A promotes the invasion and proliferation of pituitary adenoma","volume":"7","author":"An","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.biopha.2022.112686_bib6","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.bbrc.2017.07.138","article-title":"Blocking LDHA glycolytic pathway sensitizes glioblastoma cells to radiation and temozolomide","volume":"491","author":"Koukourakis","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2022.112686_bib7","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.biopha.2017.09.090","article-title":"Oxamate potentiates taxol chemotherapeutic efficacy in experimentally-induced solid ehrlich carcinoma (SEC) in mice","volume":"95","author":"El-Sisi","year":"2017","journal-title":"Biomed. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2022.112686_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085576","article-title":"Synergistic anti-cancer effect of phenformin and oxamate","volume":"9","author":"Miskimins","year":"2014","journal-title":"PLoS One"},{"issue":"1\u20132","key":"10.1016\/j.biopha.2022.112686_bib9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11010-012-1428-2","article-title":"LDH-C4: a target with therapeutic potential for cancer and contraception","volume":"371","author":"Gupta","year":"2012","journal-title":"Mol. Cell Biochem"},{"key":"10.1016\/j.biopha.2022.112686_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.632364","article-title":"Inhibition of LDH-A by oxamate enhances the efficacy of anti-PD-1 treatment in an NSCLC humanized mouse model","volume":"11","author":"Qiao","year":"2021","journal-title":"Front. Oncol."},{"issue":"5306","key":"10.1016\/j.biopha.2022.112686_bib11","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1126\/science.275.5306.1649","article-title":"Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts","volume":"275","author":"Irani","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.biopha.2022.112686_bib12","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0021-9258(18)64352-2","article-title":"The role of glycolysis in the growth of tumor cells. I. Effects of oxamic acid on the metabolism of Ehrlich ascites tumor cells in vitro","volume":"236","author":"Papaconstantinou","year":"1961","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2022.112686_bib13","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1016\/S0021-9258(18)97248-0","article-title":"The role of glycolysis in the growth of tumor cells. IV. The basis of glucose toxicity in oxamate-treated, cultured cells","volume":"240","author":"Goldberg","year":"1965","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.biopha.2022.112686_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078935","article-title":"Lactate-modulated induction of THBS-1 activates transforming growth factor (TGF)-beta2 and migration of glioma cells in vitro","volume":"8","author":"Seliger","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.biopha.2022.112686_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/nbm.3861","article-title":"Online 1 H-MRS measurements of time-varying lactate production in an animal model of glioma during administration of an anti-tumoral drug","volume":"31","author":"Cr\u00e9millieux","year":"2018","journal-title":"NMR Biomed."},{"issue":"7","key":"10.1016\/j.biopha.2022.112686_bib16","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/09553002.2016.1162921","article-title":"Hypoxia-inducible proteins HIF1\u03b1 and lactate dehydrogenase LDH5, key markers of anaerobic metabolism, relate with stem cell markers and poor post-radiotherapy outcome in bladder cancer","volume":"92","author":"Koukourakis","year":"2016","journal-title":"Int. J. Radiat. Biol."},{"issue":"35","key":"10.1016\/j.biopha.2022.112686_bib17","doi-asserted-by":"crossref","first-page":"56456","DOI":"10.18632\/oncotarget.10919","article-title":"Repurposing phenformin for the targeting of glioma stem cells and the treatment of glioblastoma","volume":"7","author":"Jiang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2022.112686_bib18","doi-asserted-by":"crossref","first-page":"6039","DOI":"10.2147\/OTT.S168981","article-title":"Phenformin and metformin inhibit growth and migration of LN229 glioma cells in vitro and in vivo","volume":"11","author":"Wang","year":"2018","journal-title":"Onco Targets Ther."},{"issue":"5","key":"10.1016\/j.biopha.2022.112686_bib19","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.3892\/ijo.2013.2080","article-title":"Effective inhibition of nasopharyngeal carcinoma in vitro and in vivo by targeting glycolysis with oxamate","volume":"43","author":"Li","year":"2013","journal-title":"Int. J. Oncol."},{"issue":"12","key":"10.1016\/j.biopha.2022.112686_bib20","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.7150\/jca.13123","article-title":"Anti-inflammatory and antitumor activity of a triple therapy for a colitis-related colorectal cancer","volume":"7","author":"Figueroa-Gonz\u00e1lez","year":"2016","journal-title":"J. Cancer"},{"issue":"16","key":"10.1016\/j.biopha.2022.112686_bib21","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.3390\/cancers13164226","article-title":"Role of inflammatory mediators, macrophages, and neutrophils in glioma maintenance and progression: mechanistic understanding and potential therapeutic applications","volume":"13","author":"Basheer","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.biopha.2022.112686_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-5728(99)00111-3","article-title":"Interleukin-17 stimulates the expression of IkappaB alpha mRNA and the secretion of IL-6 and IL-8 in glioblastoma cell lines","volume":"101","author":"Kehlen","year":"1999","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.biopha.2022.112686_bib23","doi-asserted-by":"crossref","first-page":"134","DOI":"10.7150\/ijbs.4891","article-title":"Analysis of CD137L and IL-17 expression in tumor tissue as prognostic indicators for gliblastoma","volume":"9","author":"Cui","year":"2013","journal-title":"Int J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2022.112686_bib24","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/jcmm.13938","article-title":"IL-17A promotes cell migration and invasion of glioblastoma cells via activation of PI3K\/AKT signalling pathway","volume":"23","author":"Zheng","year":"2019","journal-title":"J. Cell Mol. Med."},{"issue":"4","key":"10.1016\/j.biopha.2022.112686_bib25","first-page":"474","article-title":"TNF inhibitor pomalidomide sensitizes glioblastoma cells to EGFR inhibition","volume":"50","author":"Luo","year":"2020","journal-title":"Ann. Clin. Lab Sci."},{"key":"10.1016\/j.biopha.2022.112686_bib26","first-page":"1","article-title":"Serum cytokines in astrocytic brain tumors: a prospective study","author":"Ansari","year":"2020","journal-title":"Br. J. Neurosurg."},{"issue":"1","key":"10.1016\/j.biopha.2022.112686_bib27","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s40478-021-01163-0","article-title":"TNF\u03b1 secreted by glioma associated macrophages promotes endothelial activation and resistance against anti-angiogenic therapy","volume":"9","author":"Wei","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2022.112686_bib28","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13046-019-1085-3","article-title":"Challenges and potential of PD-1\/PD-L1 checkpoint blockade immunotherapy for glioblastoma","volume":"38","author":"Wang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.biopha.2022.112686_bib29","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/cncr.33378","article-title":"Treatment with pembrolizumab in programmed death ligand 1-positive recurrent glioblastoma: results from the multicohort phase 1 KEYNOTE-028 trial","volume":"127","author":"Reardon","year":"2021","journal-title":"Cancer"},{"issue":"23","key":"10.1016\/j.biopha.2022.112686_bib30","doi-asserted-by":"crossref","first-page":"11886","DOI":"10.18632\/oncotarget.2620","article-title":"Different effects of LDH-A inhibition by oxamate in non-small cell lung cancer cells","volume":"5","author":"Yang","year":"2014","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.biopha.2022.112686_bib31","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00066-011-0054-3","article-title":"Effects of three modifiers of glycolysis on ATP, lactate, hypoxia, and growth in human tumor cell lines in vivo","volume":"188","author":"Yaromina","year":"2012","journal-title":"Strahl. Onkol."},{"issue":"2","key":"10.1016\/j.biopha.2022.112686_bib32","doi-asserted-by":"crossref","first-page":"178","DOI":"10.7150\/jca.16387","article-title":"Targeting metabolic remodeling in triple negative breast cancer in a murine model","volume":"8","author":"Garc\u00eda-Castillo","year":"2017","journal-title":"J. Cancer"},{"issue":"3","key":"10.1016\/j.biopha.2022.112686_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150303","article-title":"Oxamate improves glycemic control and insulin sensitivity via inhibition of tissue lactate production in db\/db mice","volume":"11","author":"Ye","year":"2016","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.biopha.2022.112686_bib34","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1002\/jbmr.4142","article-title":"Lactate dehydrogenase inhibition with oxamate exerts bone anabolic effect","volume":"35","author":"Hollenberg","year":"2020","journal-title":"J. Bone Min. Res."},{"issue":"4","key":"10.1016\/j.biopha.2022.112686_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019191","article-title":"Amyloid beta resistance in nerve cell lines is mediated by the Warburg effect","volume":"6","author":"Newington","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2022.112686_bib36","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3389\/fncel.2015.00264","article-title":"Commentary: targeting LDH enzymes with a stiripentol analog to treat epilepsy","volume":"9","author":"Cho","year":"2015","journal-title":"Front. Cell Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2022.112686_bib37","first-page":"50","article-title":"Hazards posed by a banned drug--phenformin is still hanging around","volume":"14","author":"Ching","year":"2008","journal-title":"Hong Kong Med. J."},{"issue":"2","key":"10.1016\/j.biopha.2022.112686_bib38","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF01263444","article-title":"Lactic acidosis in biguanide-treated diabetics: a review of 330 cases","volume":"14","author":"Luft","year":"1978","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.biopha.2022.112686_bib39","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0300-595X(83)80048-6","article-title":"Drug and chemical-induced metabolic acidosis","volume":"12","author":"Kreisberg","year":"1983","journal-title":"Clin. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2022.112686_bib40","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejps.2016.09.014","article-title":"Lactate dehydrogenase inhibitors can reverse inflammation induced changes in colon cancer cells","volume":"96","author":"Manerba","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2022.112686_bib41","first-page":"4439","article-title":"Synergistically suppressive effects on colorectal cancer cells by combination of mTOR inhibitor and glycolysis inhibitor, Oxamate","volume":"11","author":"Xing","year":"2018","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"1","key":"10.1016\/j.biopha.2022.112686_bib42","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejps.2004.09.011","article-title":"Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles","volume":"24","author":"Bilati","year":"2005","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2022.112686_bib43","article-title":"Characterization of chitosan polymeric ethosomes capable of encapsulating hydrophobic and hydrophilic drugs prepared by a microemulsion method","author":"Liang","year":"2012","journal-title":"Wuli Huaxue Xuebao Acta Phys. Chim. Sin."},{"key":"10.1016\/j.biopha.2022.112686_bib44","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jconrel.2021.05.032","article-title":"Solid lipid nanoparticles for hydrophilic drugs","volume":"335","author":"Mirchandani","year":"2021","journal-title":"J. Control Release"},{"key":"10.1016\/j.biopha.2022.112686_bib45","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.actbio.2014.12.013","article-title":"In situ DOX-calcium phosphate mineralized CPT-amphiphilic gelatin nanoparticle for intracellular controlled sequential release of multiple drugs","volume":"15","author":"Li","year":"2015","journal-title":"Acta Biomater."},{"issue":"33","key":"10.1016\/j.biopha.2022.112686_bib46","doi-asserted-by":"crossref","first-page":"8593","DOI":"10.1016\/j.biomaterials.2011.07.057","article-title":"Strategies for the nanoencapsulation of hydrophilic molecules in polymer-based nanoparticles","volume":"32","author":"Vrignaud","year":"2011","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.biopha.2022.112686_bib47","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1021\/acs.biomac.9b00470","article-title":"Metabolite responsive nanoparticle-protein complex","volume":"20","author":"Fruehauf","year":"2019","journal-title":"Biomacromolecules"},{"issue":"4","key":"10.1016\/j.biopha.2022.112686_bib48","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3109\/14756366.2011.566221","article-title":"Oxamic acid analogues as LDH-C4-specific competitive inhibitors","volume":"26","author":"Rodr\u00edguez-P\u00e1ez","year":"2011","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"22","key":"10.1016\/j.biopha.2022.112686_bib49","first-page":"6750","article-title":"Multiple splice variants of lactate dehydrogenase C selectively expressed in human cancer","volume":"62","author":"Koslowski","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2022.112686_bib50","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cca.2019.11.032","article-title":"Diagnostic and prognostic value of the cancer-testis antigen lactate dehydrogenase C4 in breast cancer","volume":"503","author":"Cui","year":"2020","journal-title":"Clin. Chim. Acta"},{"issue":"19","key":"10.1016\/j.biopha.2022.112686_bib51","doi-asserted-by":"crossref","first-page":"19455","DOI":"10.18632\/aging.103879","article-title":"Cancer-testis antigen lactate dehydrogenase C4 in hepatocellular carcinoma: a promising biomarker for early diagnosis, efficacy evaluation and prognosis prediction","volume":"12","author":"Cui","year":"2020","journal-title":"Aging"},{"issue":"2","key":"10.1016\/j.biopha.2022.112686_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2020.112414","article-title":"Cancer\/testis antigen LDHC promotes proliferation and metastasis by activating the PI3K\/Akt\/GSK-3\u03b2-signaling pathway and the in lung adenocarcinoma","volume":"398","author":"Chen","year":"2021","journal-title":"Exp. Cell Res."},{"issue":"6","key":"10.1016\/j.biopha.2022.112686_bib53","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s12010-016-2040-9","article-title":"Characterization and inhibitor screening of plateau Zokor lactate dehydrogenase C4","volume":"179","author":"He","year":"2016","journal-title":"Appl. Biochem Biotechnol."},{"issue":"1","key":"10.1016\/j.biopha.2022.112686_bib54","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0167-4838(97)00090-3","article-title":"Selective inhibition of the sperm-specific lactate dehydrogenase isozyme-C4 by N-isopropyl oxamate","volume":"1343","author":"Wong","year":"1997","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.biopha.2022.112686_bib55","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.3892\/mmr.2016.4963","article-title":"Expression of lactate dehydrogenase C in MDA-MB-231 cells and its role in tumor invasion and migration","volume":"13","author":"Kong","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"4","key":"10.1016\/j.biopha.2022.112686_bib56","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/19396368.2014.902144","article-title":"Effect of oxamic analogues on functional mice sperm parameters","volume":"60","author":"Cordero-Mart\u00ednez","year":"2014","journal-title":"Syst. Biol. Reprod. Med."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222000749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222000749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:50:47Z","timestamp":1760100647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222000749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":56,"alternative-id":["S0753332222000749"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.112686","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oxamate targeting aggressive cancers with special emphasis to brain tumors","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.112686","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112686"}}